Literature DB >> 6759042

High-density lipoprotein cholesterol: methods and clinical significance.

P N Durrington.   

Abstract

The known limitations and advantages of methods for determining serum high-density lipoprotein (HDL) cholesterol concentration are reviewed with special emphasis on the applicability of each method to clinical medicine. The evidence for and against the relevance of serum HDL cholesterol to the prediction of the likelihood of an individual man or woman developing clinically evident ischemic heart disease is discussed. The possibility that HDL subfractions may be more relevant to this issue is also discussed. Information about serum HDL cholesterol concentration in diseases other than ischemic heart disease is reviewed. The effect of diet, body-weight, exercise, cigarette-smoking, alcohol intake, and hyperlipoproteinemia and the effect of modification of these factors on serum HDL cholesterol levels is discussed. Finally, a practical approach to the patient with a low concentration of serum HDL cholesterol is suggested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759042     DOI: 10.3109/10408368209082589

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  4 in total

1.  Analysis of membrane fluidity alterations and lipid disorders in type I diabetic children and adolescents.

Authors:  C Watała; M Kordacka; A Loba; Z Jóźwiak; S Nowak
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

2.  Subclinical and reversible hepatic effects of occupational exposure to trichloroethylene.

Authors:  T Nagaya; N Ishikawa; H Hata; T Otobe
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

3.  The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.

Authors:  M I Mackness; C Abbott; S Arrol; P N Durrington
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

4.  Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women.

Authors:  Joel Perrella; Mauricio Berco; Anthony Cecutti; Alan Gerulath; Bhagu R Bhavnani
Journal:  Lipids Health Dis       Date:  2003-06-20       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.